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Voiding Dysfunction
Outcomes of Transurethral Removal of Intravesical or 
Intraurethral Mesh Following Midurethral Sling Surgery
Dae-Jin Jo, Young-Suk Lee, Tae-Hee Oh, Dong-Su Ryu, Kyung-Won Kwak
Department of Urology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea
Purpose: To present outcomes of transurethral removal (TUR) of intravesical or intra-
urethral mesh after midurethral slings. 
Materials and Methods: This was a retrospective chart review of 23 consecutive women: 
20 with intravesical mesh and 3 with intraurethral mesh. 
Results: To remove the mesh, transurethral resection with an electrode loop (TUR-E) 
was used in 16 women and transurethral resection with a holmium laser (TUR-H) was 
used in 7. The median follow-up was 2.1 months. Twenty-six percent of the women (6/23) 
had a mesh remnant: 6.2% (1/16) of the women treated with TUR-E and 71.4% (5/7) 
of the women treated with TUR-H. Of the 5 women treated with TUR-H, 3 underwent 
concomitant transvaginal removal. On the follow-up cystoscopic exam, a mesh remnant 
was observed in 3 women (1 treated with TUR-E and 2 treated with TUR-H). Vesico-vag-
inal fistulas were found in 2 women during and after TUR-E, respectively. Stress uri-
nary incontinence recurred in 1 woman.
Conclusions: TUR-E has a high success rate but carries a risk of bladder perforation. 
Complete resection using TUR-H depends on the location of the mesh and the range 
of motion of the instrument. 
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INTRODUCTION
Tension-free vaginal tape (TVT) is now the treatment of 
choice for female stress urinary incontinence because of its 
ease of use, minimal invasiveness, and high success rate 
[1]. However, this technique can have several compli-
cations. Properly identifying and treating complications 
remains critical for the practicing physician. Intravesical 
and intraurethral mesh are troublesome complications 
clinically and legally. Mesh in the bladder or urethra fol-
lowing midurethral sling has been reported to occur in 
somewhere between less than 1% to 6% of patients and can 
result from intraoperative needle penetration or tape ero-
sion [2-4]. Even though the trans-obturator tape (TOT) pro-
cedure has less risk of lower urinary tract injury, surgeons 
should handle with care to prevent this complication. 
Bladder injury that is recognized during the operation is 
not usually related to long-term sequelae [5,6]. However, 
when bladder injury is missed or the mesh erodes into the 
bladder or urethra, patients might suffer from painful uri-
nation, recurrent urinary tract infection, irritative or ob-
structive symptoms, and hematuria. 
Since the first case of urethral mesh erosion was reported 
in 2001, several case series have provided various techni-
ques to manage this difficult complication [7,8-10]. Intra-
vesical or intraurethral mesh can be removed by open sur-
gery (cystorrhapy or urethrolysis and urethroplasty) or en-
doscopic surgery. However, evidence is lacking on the effi-
cacies of these techniques. 
The objective of this study was to determine the efficacy 
and complication associated with transurethral removal 
(TUR) of the intravesical or intraurethral mesh following 
midurethral sling procedures. Korean J Urol 2011;52:829-834
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FIG. 1. Pictures of the transurethral 
resection with an electrode loop for 
intravesical mesh. (A) Preoperative 
finding: stone encrustation. (B) Posto-
perative finding: no mesh remained 
and perivesical fat was seen. 
FIG. 2. Pictures of the transurethral 
resection with a holmium laser for 
intravesical mesh. (A) Preoperative 
finding: stone encrustation. (B) Posto-
perative finding: no mesh remained. 
MATERIALS AND METHODS
A retrospective chart review was performed for women who 
had undergone transurethral surgery for bladder or ure-
thral mesh between January 2002 and December 2010. A 
total of 23 consecutive women were identified, and their 
demographics, midurethral sling procedures, and removal 
procedures were reviewed. The surgical outcomes and com-
plications were evaluated. To remove the mesh, transure-
thral resection with an electrode loop (TUR-E) was used un-
til March 2010, when a holmium laser became available in 
the study center. Thereafter, transurethral resection with 
a holmium laser (TUR-H) was performed. The usual surgi-
cal techniques of TUR-E and TUR-H are described below. 
1. Transurethral resection with an electrode loop
TUR-E was performed for 15 women with intravesical 
mesh and 1 woman with intraurethral mesh. With the pa-
tient under spinal anesthesia in the lithotomy position, a 
urethro-cystoscopic exam was performed with a 25 Fr re-
sectoscope and a 0, 30, and 70 degree telescope. When the 
stone was attached to the mesh, lithotripsy was performed 
with a lithoclast. The mesh was then resected with an elec-
trode loop until it was not visible or the perivesical fat was 
reached. The resected mesh was removed by foreign body 
forceps. After confirming that no mesh remained in the 
bladder or urethra a 16 Fr Foley catheter was inserted and 
left in place for a median of 6 days (range, 3 to 29 days). The 
median operation time was 57 minutes (40 to 135 minutes), 
and the median hospital stay was 8 days (4 to 36 days). 
Pictures of the TUR-E are provided in Fig. 1.
Seven patients were treated with the TUR-H procedure 
with a rigid scope: 5 cases of intravesical mesh and 2 cases 
of intraurethral mesh. The surgery was similar to that for 
TUR-E except a holmium laser was used. When the stone 
was observed, lithotripsy was performed with the laser. 
The mesh was excised as near to the bladder or urethral 
mucosa as possible. When the laser could not cut deeply 
enough and strings or a portion of the mesh remained, the 
remnant was evaporated by the laser. The median energy 
used was 4.3 kJ (range, 0.7 to 14.9 kJ). After confirming that 
no mesh remained in the bladder or urethra, a 16 Fr Foley 
catheter was inserted and left in place for a median of 1 day 
(range, 1 to 2 days). The median operation time was 125 mi-
nutes (range, 30 to 180 minutes) and the median hospital 
stay was 4.5 days (range, 3 to 10 days). Pictures of the 
TUR-H are provided in Fig. 2.
Three women required concomitant transvaginal sur-
gery for remnant mesh after TUR-H: 2 with intravesical 
mesh and 1 with intraurethral mesh. A midline vaginal in-
cision was made and submucosal dissection was performed 
with mezenbaum scissors. After identifying the mesh, it Korean J Urol 2011;52:829-834
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FIG. 3. Pictures of the combined 
transvaginal and transurethral resec-
tion with a holmium laser for intraure-
thral mesh. (A) Preoperative finding: 
stone encrustation. (B) Postoperative 
finding: no mesh remained after 
transvaginal removal.
TABLE 1. Patient demographics and clinical characteristics
Total
n=23
TUR-E
n=16
TUR-H
n=7
Age (median, range, years)
BMI (median, range, kg/m
2)
No. of delivery (median, range)
Pts. no. of hysterectomy (n, %)
Pts. no. of menopause (n, %)
Midurethral sling procedure (n, %)
    Transobturator 
    Retropubic 
    Single incision sling 
    Unknown
Location of mesh (n, %)
    Bladder
    Urethra
Stone (n, %)
Duration from manifestation to 
diagnosis (median, range, months)
Duration from sling to mesh removal 
(median, range, months)
Follow-up duration after mesh removal 
(median, range, months)
  51 (40-67)
  22 (18-28)
2 (1-5)
2 (8.7)
10 (43.5) 
11 (47.8)
  8 (34.7)
1 (4.3)
  3 (13.0)
20 (87.0)
  3 (13.0)
17 (73.9)
        7.3 (0.8-113.1) 
      31.3 (2.2-247.6)
      2.1 (0.3-35.9)
  50 (46-62)
  22 (20-28)
2 (2-5)
1 (6.3)
  6 (37.5)
  8 (50.0)
  7 (43.7)
0
1 (6.3)
15 (93.7)
1 (6.3)
12 (75.0)
       7.6 (0.8-113.1)
     26.3 (2.2-247.6)
     1.7 (0.3-35.9)
  46 (40-67)
  20 (18-28)
2 (1-3)
  1 (14.3)
  4 (57.1)
  3 (42.8)
  1 (14.3)
  1 (14.3)
  2 (28.6)
  5 (71.4)
  2 (28.6)
  5 (71.4)
     6.7 (2.0-12.0)
     36.6 (8.3-162.2)
   2.3 (0.5-7.4)
TUR-E: transurethral resection with electrode loop, TUR-H: transurethral resection with holmium laser, BMI: body mass index
was grasped with Kelly forceps and further dissection pro-
ceeded toward the exposed side while carefully maintain-
ing traction on the mesh. After exposing the cut edge of the 
mesh through the vaginal incision, the whole exposed por-
tion of the mesh was resected and removed. After removing 
the mesh, a cystoscopic exam excluded any mesh 
remnants. The wound was closed layer-by-layer with 3-0 
Vicryl sutures. A Foley catheter was left in place for a me-
dian of 14 days (range, 6 to 21 days). The median operation 
time was 215 minutes (range, 180 to 220 minutes) and the 
median hospital stay was 8 days (range, 6 to 22 days). 
Pictures of the combined transvaginal and TUR-H proce-
dures are provided in Fig. 3.
RESULTS 
Patient demographics and the clinical characteristics of a 
total of 23 women are described in Table 1 according to the 
removal technique. Twenty women had intravesical mesh 
and 3 had intraurethral mesh. Sixteen women had the 
TUR-E procedure and 7 women had the TUR-H procedure. 
At the time of surgery, the median age was 51 years (range, 
40 to 67 years). The median period between the mid-
urethral sling and mesh removal was 31.3 months (range, 
2.2 to 247.6 months), and the median follow-up period was 
2.1 months (range, 0.3 to 35.9 months) after mesh removal. 
The previous midurethral sling procedures were 11 trans-
obturator slings, 8 retropubic slings, 1 single incision sling, 
and 3 which were not identified. Seventeen women (73.9%) 
had calculi. Most women presented with multiple symp-
toms, including dysuria, hematuria, and irritative or ob-
structive urinary symptoms. 
Table 2 summarizes the preoperative findings, surgical 
outcomes, and complications for all 23 cases. Overall, 6 Korean J Urol 2011;52:829-834
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TABLE 2. Summary of the 23 cases 
Case 
no.
Age 
(years)
MUS type
Location of
mesh
Stone Type of TUR  Remnant mesh Complications
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
45
50
51
62
46
52
40
46
46
53
49
47
62
47
67
62
60
61
45
57
52
50
60
Retropubic
Retropubic
Retropubic
Retropubic
Retropubic
Retropubic
Retropubic
Transobturator
Transobturator
Transobturator
Transobturator
Transobturator
Transobturator
Transobturator
Transobturator
Unknown
Transobturator
Retropubic 
Minisling
Transobturator
Unknown
Transobturator
Unknown
Lt. lateral 
Dome
Bladder neck
Bladder neck
Anterior wall
Anterior wall
Bladder neck
Anterior wall
Lt. lateral 
Bladder neck
Bladder neck
Rt. lateral 
Bladder neck
Bladder neck
Urethra
Rt. lateral 
Lt. lateral 
Bladder neck 
Rt. trigone
Urethra
Bladder neck
Bladder neck
Urethra 
+
+
+
+
-
+
-
+
+
+
-
+
+
-
+
+
+
+
-
-
+
+
+
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-E
TUR-H
TUR-H
TUR-H
TUR-H
TUR-H + TVR
TUR-H + TVR
TUR-H + TVR
-
-
-
-
-
-
-
-
+ (re-TUR-E)
-
-
-
-
-
-
-
-
+
-
+
-
-
-
-
-
-
-
-
-
-
-
-
VVF 
VVF
-
-
-
-
-
-
-
-
Recurrence of SUI
-
-
-
MUS: midurethral sling, TUR: transurethral removal, TUR-E: transurethral resection with electrode loop, TUR-H: transurethral re-
section with holmium laser, TVR: transvaginal removal, VVF: vesico-vaginal fistula, SUI: stress urinary incontinence
women (26%) had a mesh remnant after transurethral sur-
gery: 1 woman (6.2%) after TUR-E and 5 women (71.4%) 
after TUR-H. The woman who had a mesh remnant after 
TUR-E underwent repeat TUR-E for the remnant, and no 
mesh remained on the follow-up cystoscopic exam. Of the 
5 women who had remnant mesh after TUR-H, 3 under-
went concomitant transvaginal removal. On the post-
operative cystoscopic exam, 2 women had remnant mesh 
after TUR-H. One woman had transvaginal removal with 
no mesh visible on the follow-up cystoscopic exam. In the 
other woman, a string of the mesh remained. She wanted 
to delay additional treatment for the remaining mesh be-
cause she had none of the preoperative symptoms. 
Two cases of vesico-vaginal fistulas occurred in women 
treated with TUR-E. One case was found during the 
TUR-E, and the fistula tract was immediately repaired 
transvaginally. A Foley catheter was placed for 29 days and 
no sequelae were observed during 9.5 months of follow-up. 
The other case was found 15 days after TUR-E. The woman 
experienced continuous urine leakage 7 days after the 
Foley catheter was removed. On the vaginal exam, an ap-
proximately 5 mm fistula tract was observed. Transvagi-
nal fistulectomy was performed and a Foley catheter was 
placed for 21 days. No sequelae were observed during 35.5 
months of follow-up. One case of stress incontinence 
(Stamey grade I) recurred in a woman who had remaining 
intraurethral mesh after TUR-H. 
DISCUSSION
In this retrospective study, 26% of women (6/23) had a mesh 
remnant after transurethral removal of intravesical or in-
traurethral mesh. Mesh exposure in the bladder or urethra 
is an uncommon but troublesome complication of mid-
urethral slings. Several authors have described their ap-
proaches to this difficult problem, with no consensus on the 
best approach [11-16]. Frenkl et al proposed a treatment 
algorithm after reviewing 22 cases of iatrogenic foreign 
bodies in the bladder and urethra following pelvic floor sur-
gery [17]. They recommended cystorrhaphy or urethro-
plasty for mesh erosion of the lower urinary tract. They 
commented on the technical difficulties of endoscopic re-
section of the mesh due to the encrusted stone material and 
the difficulty in applying tension to the mesh during 
resection. However, there are more positive outcomes for 
endoscopic mesh removal. Standard transurethral re-
section had success rates of 90% to 100% in several case ser-
ies with a small number of patients [7,17-19]. With the elec-
trode loop, the mesh can be resected down to the sub-
mucosal portion. The electrode loop can also resect mesh 
in the bladder neck or urethra. Our series also showed a 
high success rate (93.7% [15/16]) after the TUR-E proce-
dure. The location of the mesh did not affect the result. On 
the contrary, the holmium laser completely removed the 
mesh in only 28% of women (2/7). Some case reports have Korean J Urol 2011;52:829-834
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described the holmium laser as being effective for removing 
mesh [16,18,19]. However, this method leaves the possi-
bility of remnant mesh exposure. Doumouchtsis et al re-
ported that 4 of 6 women had recurrent erosion after tran-
surethral resection using a holmium laser [20]. The hol-
mium laser allows sharp incision of the mesh at the en-
trance and exit points. However, complete excision is diffi-
cult with a rigid cystoscope when the mesh is located in the 
bladder neck or urethra. Of the 3 successful cases of hol-
mium laser excision reported by Giri et al, none were in the 
bladder neck or urethra, and a flexible instrument was 
used [16]. In the present study, the mesh was in the bladder 
neck or urethra in all 5 cases with mesh remaining after 
TUR-H, and we used a rigid scope. Therefore, we suggest 
that complete removal of the mesh using TUR-H depends 
on the location of the mesh and the range of motion of the 
instrument. Another reason for the low success rate after 
TUR-H might be less experience with the technique using 
holmium laser. 
Two cases of vesico-vaginal fistulas were found during 
or after the TUR-E procedure. As mentioned above, one ad-
vantage of the electrode loop is that it can resect the mesh 
down to the submucosal portion. However, this resection 
carries a relatively high risk of bladder or urethral 
perforation. Because damaged urethral or bladder mucosa 
is atrophic, the risk of perforation may be increased. A fac-
tor requiring deep resection is the difficulty in allowing ten-
sion to the mesh. Two groups reported a combined endo-
scopic laparoscopic tape removal method [8,15]. In this 
method, a laparoscopic trocar was inserted suprapubically 
into the bladder under cystoscopic control. Under traction 
and fixation by suprapubically introduced forceps, the tape 
was cut and extracted transurethrally. A disadvantage of 
this technique is that it requires an additional bladder 
tract, which can increase the hospital stay and morbidity. 
To avoid bladder or urethral perforation, transurethral re-
section should be carried out carefully. Oh and Ryu recom-
mended transvaginal finger-guided resection [21]. Never-
theless, transurethral resection using an electrode loop for 
intraurethral mesh might have a higher possibility of ure-
thral perforation or incomplete resection. Also, with a hol-
mium laser and rigid scope, it is difficult to remove the ure-
thral mesh completely. Thus, we do not recommend tran-
surethral surgery for urethral mesh.
All of the women had resolution of the preoperative lower 
urinary tract symptoms. The median duration from the 
manifestation of symptoms to diagnosis was more than 7 
months. The possibility of unrecognized tape perforation 
or erosion and cystosopic exam should be considered in pa-
tients with lower urinary tract symptoms after a mid-
urethral sling procedure. Stress urinary incontinence re-
curred in 1 woman who had a mesh remnant after TUR-H. 
She wanted to delay further treatment because the grade 
was minimal and her preoperative symptom was resolved. 
Given these results, transurethral resection wolud have a 
good functional outcome and low risk recurrence of stress 
incontinence. 
This was a retrospective study and included a small num-
ber of cases. However, there are only limited data on the 
effectiveness of transurethral management for bladder or 
urethral mesh. Our results can provide information on the 
outcomes and complications of different transurethral re-
moval techniques and can help physicians to choose the 
best treatment modality. 
CONCLUSIONS
Transurethral surgery is associated with low morbidity 
and is familiar to urologists. To remove intravesical or in-
traurethral mesh after midurethral sling procedures, 
TUR-E has a high success rate, although it has a high risk 
of bladder perforation. In contrast, TUR-H has less risk of 
tissue damage, but complete resection seems to depend on 
the location of the mesh and the range of motion of the 
instrument. The evidence for TUR-H is not sufficient to 
conclude that this is an ineffective method for mesh re-
moval; however, it should be performed in selected 
patients. Transurethral resection has good functional out-
comes and a low risk of recurrence of stress incontinence. 
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